
Journal of Medicinal Chemistry p. 119 - 127 (1989)
Update date:2022-07-29
Topics:
Anderson, Wayne K.
Bhattacharjee, Debkumar
Houston, D. Michael
A series of bis(carbamate) derivatives of 1,2-substituted 4,5-bis(hydroxymethyl)imidazoles were prepared and evaluated against murine P388 lymphocytic leukemia.Electron-withdrawing substituents at either N-1 or C-2 gave rise to inactive compounds.However, electron-donating substituents gave active compounds and the 2-(methylthio)-1-methyl derivative 2i (carmethizole), as the bis(N-methylcarbamate), was found to be very active.The derivative 2i, referred to by the name carmethizole, was also shown to be active against the MX-1 mammary xenograft, the human amelanotic melanoma cell line (LOX) xenograft, the M5076 sarcoma, and L1210 lymphocytic leukemia.The solution stability, water solubility, pKa, and log P of carmethizole are also reported.
View MoreShanxi Tongji Pharmaceuticals Co., Ltd.
Contact:+86-359-3024784
Address:Xikuang South Road, Ruicheng County , Shanxi
Buffett (China) Holding Co.,Ltd
Contact:4006570891
Address:
Taizhou Sunny Chemical Co.,Ltd
Contact:+86-523-86920899 +86-13951172783
Address:No.11 Xingyuang road, Gaoyong Chemical Industry Park, Gaogang Jiangsu China
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Doi:10.1055/s-1988-27551
(1988)Doi:10.1002/hlca.200800410
(2009)Doi:10.1016/j.tetlet.2009.04.060
(2009)Doi:10.1021/ol901096d
(2009)Doi:10.1016/j.jorganchem.2008.04.030
(2008)Doi:10.1016/j.tetlet.2009.04.102
(2009)